MétaCan
Menu
Back to cohort
Record W2733097072

Response of breast cancer cell lines to aminoflavone (NSC 686288) is associated with histone H2AX phosphorylation and estrogen receptor expression

2006· article· en· W2733097072 on OpenAlexaff
Melinda K. Wilson, Erica L. Stone, Michele Vítolo, Kurt Bachman, Brian Leyland‐Jones, Angelika M. Burger, Edward A. Sausville

Bibliographic record

VenueCancer Research · 2006
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicEstrogen and related hormone effects
Canadian institutionsMcGill University
Fundersnot available
KeywordsAryl hydrocarbon receptorEstrogen receptorCancer researchDNA damageCell cultureCell cycleCell growthMolecular biologyEstrogen receptor alphaChemistryCancerBreast cancerBiologyInternal medicineMedicineDNATranscription factorBiochemistry
DOInot available

Abstract

fetched live from OpenAlex

555 Aminoflavone (AF; 5-amino-2,3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one; NSC 686288) is a novel anticancer agent which has entered early clinical trials sponsored by the US-National Cancer Institute. AF has shown exquisite sensitivity toward a limited number of human tumor cell lines including lung, ovarian, renal, and breast carcinomas. AF is a ligand of the aryl hydrocarbon receptor (AhR). Its activity has been linked to the presence of cytoplasmic AhR, translocation of the AhR:AF complex to the nucleus followed by induction of cytochrome P450 (CYP) 1A1 and DNA damage caused by metabolites. The latter is exemplified by the occurrence of gamma-histone 2AX (H2AX) phosphorylation consistent with induction of DNA single-strand breaks and DNA-protein cross-links. In this study, we examined determinants of AF response in a panel of molecularly well defined breast cell lines, they include: MCF-7 (estrogen receptor positive, ER+), T47D (ER+), MCF-7/HER2-18 (ER+), MDA-MB-231 (ER-), and MCF10A (ER-). Antiproliferative effects were measured by MTT assay, and concentrations that inhibit cell growth to 50 % of control (IC50) were established for each cell line. The response to AF was compared to ER status, AhR localization, and gamma-H2AX foci formation in a time and concentration dependent manner by dual immunofluorescence labeling. We found that AF potently inhibited the growth of ER+ breast cancer cell lines at nanomolar concentrations (mean IC50s: MCF-7 = 18 nM; MCF-7/HER2-18 = 20 nM; T47D = 14 nM), whereas the ER- breast cancer cell line MDA-MB-231 (IC50 = 25 μM) and the immortalized ER- breast cell line MCF10A (IC50 = 3 μM) were several log-fold less sensitive. In cell lines that were exquisitely sensitive to AF, AhR expression was found to be more cytoplasmic than nuclear. In contrast, the cell lines resistant to AF showed a predominantly nuclear AhR localization. Gamma-H2AX foci occurred between 6 to 24 hours only in AF responsive ER+ breast cancer cells treated at their respective IC50s, but not in the ER- cell lines. Interestingly, MCF-7/HER2-18 (IC50 = 20 nM, IC100 = 375 nM), which is a HER2/neu receptor overexpressing Herceptin and tamoxifen resistant subclone of MCF-7 (IC50 4-OH-tamoxifen >1μM), retained its sensitivity to AF if compared to the parental MCF-7 cells (IC50 = 18 nM, IC100 = 300 nM). These observations suggest that AF, unlike other antineoplastic agents, requires a specific activation to cause DNA damage and that AhR and its cross talk with ER are determinates of this specific response. AF activity in Herceptin and tamoxifen resistant MCF-7 cells indicates that AF might provide a new treatment strategy for hormone-refractory ER positive breast cancers and that this hypothesis should be tested in a larger sample cohort and in vivo models.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.319
Teacher spread0.306 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicEstrogen and related hormone effectsFrench-language works237,207